283 related articles for article (PubMed ID: 23954421)
1. An in silico approach for understanding the molecular evolution of clinically important metallo-beta-lactamases.
Pal A; Tripathi A
Infect Genet Evol; 2013 Dec; 20():39-47. PubMed ID: 23954421
[TBL] [Abstract][Full Text] [Related]
2. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
[TBL] [Abstract][Full Text] [Related]
3. Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa.
Kazmierczak KM; Rabine S; Hackel M; McLaughlin RE; Biedenbach DJ; Bouchillon SK; Sahm DF; Bradford PA
Antimicrob Agents Chemother; 2016 Feb; 60(2):1067-78. PubMed ID: 26643349
[TBL] [Abstract][Full Text] [Related]
4. Preferential selection of IMP and VIM metallo-beta-lactamases by imipenem in Pseudomonas aeruginosa.
Walsh F; Bracher S; Turner P; Amyes S
Chemotherapy; 2007; 53(6):407-9. PubMed ID: 17934261
[TBL] [Abstract][Full Text] [Related]
5. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
Dai W; Sun S; Yang P; Huang S; Zhang X; Zhang L
Infect Genet Evol; 2013 Mar; 14():1-7. PubMed ID: 23220359
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in
Wachino J-i; Jin W; Norizuki C; Kimura K; Tsuji M; Kurosaki H; Arakawa Y
Microbiol Spectr; 2024 Mar; 12(3):e0234423. PubMed ID: 38315122
[TBL] [Abstract][Full Text] [Related]
7. High incidence of New Delhi metallo-beta-lactamase-producing Klebsiella pneumoniae isolates in Sharjah, United Arab Emirates.
Dash N; Panigrahi D; Zarouni MA; Darwish D; Ghazawi A; Sonnevend A; Pal T; Yasin F; Hadi SA
Microb Drug Resist; 2014 Feb; 20(1):52-6. PubMed ID: 23992285
[TBL] [Abstract][Full Text] [Related]
8. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
[TBL] [Abstract][Full Text] [Related]
9. Metallo-beta-lactamase-producing imipenem-resistant Pseudomonas aeruginosa clinical isolates in a university teaching hospital in Malaysia: detection of IMP-7 and first identification of IMP-4, VIM-2, and VIM-11.
Khosravi Y; Tee Tay S; Vadivelu J
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):294-6. PubMed ID: 20462725
[TBL] [Abstract][Full Text] [Related]
10. Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant Enterobacterales.
Ooi N; Lee VE; Chalam-Judge N; Newman R; Wilkinson AJ; Cooper IR; Orr D; Lee S; Savage VJ
J Antimicrob Chemother; 2021 Jan; 76(2):460-466. PubMed ID: 33152764
[TBL] [Abstract][Full Text] [Related]
11. Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1.
Moloughney JG; D Thomas J; Toney JH
FEMS Microbiol Lett; 2005 Feb; 243(1):65-71. PubMed ID: 15668002
[TBL] [Abstract][Full Text] [Related]
12. A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin.
Giske CG; Gezelius L; Samuelsen Ø; Warner M; Sundsfjord A; Woodford N
Clin Microbiol Infect; 2011 Apr; 17(4):552-6. PubMed ID: 20597925
[TBL] [Abstract][Full Text] [Related]
13. Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan.
Lin YC; Sheng WH; Chen YC; Chang SC; Hsia KC; Li SY
Int J Antimicrob Agents; 2010 May; 35(5):439-43. PubMed ID: 20106635
[TBL] [Abstract][Full Text] [Related]
14. Detection of metallo-β-lactamases producing Acinetobacter baumannii using microbiological assay, disc synergy test and PCR.
Purohit M; Mendiratta DK; Deotale VS; Madhan M; Manoharan A; Narang P
Indian J Med Microbiol; 2012; 30(4):456-61. PubMed ID: 23183473
[TBL] [Abstract][Full Text] [Related]
15. bla(IMP) and bla(VIM) mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India.
Amudhan MS; Sekar U; Kamalanathan A; Balaraman S
J Infect Dev Ctries; 2012 Nov; 6(11):757-62. PubMed ID: 23277500
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants.
Cheng Z; Bethel CR; Thomas PW; Shurina BA; Alao JP; Thomas CA; Yang K; Marshall SH; Zhang H; Sturgill AM; Kravats AN; Page RC; Fast W; Bonomo RA; Crowder MW
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468463
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan.
Huang YT; Chang SC; Lauderdale TL; Yang AJ; Wang JT
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):211-6. PubMed ID: 17521840
[TBL] [Abstract][Full Text] [Related]
18. Activity of carbapenems with ME1071 (disodium 2,3-diethylmaleate) against Enterobacteriaceae and Acinetobacter spp. with carbapenemases, including NDM enzymes.
Livermore DM; Mushtaq S; Morinaka A; Ida T; Maebashi K; Hope R
J Antimicrob Chemother; 2013 Jan; 68(1):153-8. PubMed ID: 22945917
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of metallo-beta-lactamase-producing acinetobacter baumannii in a teaching hospital in Tabriz, Iran.
Peymani A; Nahaei MR; Farajnia S; Hasani A; Mirsalehian A; Sohrabi N; Abbasi L
Jpn J Infect Dis; 2011; 64(1):69-71. PubMed ID: 21266761
[TBL] [Abstract][Full Text] [Related]
20. SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model.
Leiris S; Coelho A; Castandet J; Bayet M; Lozano C; Bougnon J; Bousquet J; Everett M; Lemonnier M; Sprynski N; Zalacain M; Pallin TD; Cramp MC; Jennings N; Raphy G; Jones MW; Pattipati R; Shankar B; Sivasubrahmanyam R; Soodhagani AK; Juventhala RR; Pottabathini N; Pothukanuri S; Benvenuti M; Pozzi C; Mangani S; De Luca F; Cerboni G; Docquier JD; Davies DT
ACS Infect Dis; 2019 Jan; 5(1):131-140. PubMed ID: 30427656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
